Your session is about to expire
← Back to Search
Sipuleucel-T + BAT for Prostate Cancer
Study Summary
This trial seeks to improve current cancer treatment for prostate cancer patients with a new therapy combining BAT & Sipuleucel-T.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any spaces remaining in this clinical experiment?
"The details on clinicaltrials.gov indicate that this particular trial is no longer in search of patients. First posted November 1st 2023, it has since been updated last October 20th and cannot accept new participants anymore; however, there are still 1281 other medical experiments presently looking for volunteers to join their research teams."
Has the combination of Testosterone Cypionate and Sipuleucel-T obtained regulatory approval?
"The safety of Testosterone Cypionate + Sipuleucel-T is estimated to be a 2 on our scale, as this Phase 2 trial only has evidence supporting its security but no data confirming its effectiveness."
Share this study with friends
Copy Link
Messenger